Synchron, which is developing a brain-computer interface that helps paralysis patients text, email, and shop online, raises $40M Series B led by Khosla Ventures (Andrea Park/FierceBiotech)

Andrea Park / FierceBiotech:Synchron, which is developing a brain-computer interface that helps paralysis patients text, email, and shop online, raises $40M Series B led by Khosla VenturesAfter years of focusing on all things artificial intelligence, the buzziest buzz in medtech now centers not on robots and algorithms
Click here to read full news..

guestpostbloggingwork

websitextra

,synchron series khosla venturesparkfiercebiotech ,synchron khosla venturesparkfiercebiotech ,series khosla venturesparkfiercebiotech

Related Post

Quantifying Uncertainty: Measuring the Confidence of Every Prediction

Imagine standing at the edge of a dense forest, holding a...

Latest Post

גלו מדוע מאיירס בטוח לקנייה היא בחירת השקעה חכמה

כשמדובר ברכישה משמעותית, אתם רוצים לוודא שהמוצר בו אתם...

Bold, Bright, and Botanical: How Heliconias Make Gardens Pop

Heliconia is a plant that demands attention. With vivid...

SOCIALS